Vishal Gupta, Ph.D.
Dr. Vishal Gupta is the Executive Vice President, Global CMC and CDMO Services. Dr. Gupta has extensive industry and private equity experience in a career spanning over 20 years.
Prior to joining Frontage, Vishal was Chief Scientific Officer and Senior Vice President at Mallinckrodt Specialty Generics where he was responsible for Generics and 505(b)(2) R&D including CMC, Clinical Pharmacology, Regulatory Affairs, Project Management, Portfolio Management, and Strategy. He served as Senior Vice President, US R&D at Alvogen; Chief Scientific Officer, SVP and Head of Global R&D at Impax Laboratories, and Chief Scientific Officer, SVP at CorePharma. He also served in positions of increasing responsibility at Pfizer and Mallinckrodt early in his career.
Vishal was an Adjunct Assistant Professor at Midwestern College of Pharmacy, Chicago, IL and St. Louis College of Pharmacy, St. Louis, MO. He served the American Association of Pharmaceutical Scientists (AAPS) in various roles including Chair of Pharmaceutical Technology, and Manufacturing Science and Engineering Sections. He is also a Six Sigma Black Belt.
Vishal holds a PhD in Pharmaceutics from The University of Georgia, Athens, GA, an MBA in Strategy and Finance from Washington University, St. Louis, MO, an MS in Pharmaceutics from Indian Institute of Technology, Banaras Hindu University, India, and a BS in Pharmacy from Amravati University, India.
